Trials / Recruiting
RecruitingNCT06670443
Electrical Stimulation for Respiratory and Leg Muscles Impact on COPD Patients
Electrical Stimulation for Respiratory and Leg Muscles Impact on Pulmonary Function and Leg Restless Syndrome in COPD Patients
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Electrical neuromuscular stimulation electrode patches will be applied over the intercostal respiratory muscles and leg muscles In addition to conventional pulmonary rehabilitation
Detailed description
Intervention group: active NMES (350 μs pulses - 50 Hz frequency) will be applied at the lower third of the thigh, just above the patella, and the proximal electrode 5-10 cm below the anterior superior iliac spine for quadriceps muscle stimulation, and for intercostal muscles stimulation, NMES will be bilaterally, parallel to the ribs, in the intercostal space. The proximal electrode will be positioned close to the sternum, and the distal electrode laterally, close to the midaxillary line. In addition to conventional pulmonary rehabilitation program that comprised diaphragmatic and pursed lips breathing. control group: placebo NMES at the same points in addition to the same conventional pulmonary rehabilitation program
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | experimental group | Electrical neuromuscular stimulation electrode patches will be applied over the intercostal respiratory muscles and leg muscles (placed superficially just below each knee, over the head of the fibula, in close proximity to the common peroneal nerve). |
| DEVICE | control group | Placebo electrical neuromuscular stimulation electrode patches will be applied over the intercostal respiratory muscles and leg muscles (placed superficially just below each knee, over the head of the fibula, in close proximity to the common peroneal nerve). |
Timeline
- Start date
- 2025-01-10
- Primary completion
- 2025-11-30
- Completion
- 2025-12-30
- First posted
- 2024-11-01
- Last updated
- 2025-09-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06670443. Inclusion in this directory is not an endorsement.